Barusiban Subcutaneously for Reducing Implantation Failure Due to Uterine Contractions
Clinical trial NCT01723982 · COMPLETED
Trial details
- NCT number
- NCT01723982
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2014-10-01
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.